在FDA不良事件报告系统 (FAERS) 数据库中对eplerenone的分析:重点关注整体患者群体和性别特定的子组
Xin Guan1, Yusi Yang1, Xinru Li1
1Department of Cardiology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences Tongji Shanxi Hospital, Taiyuan, China.
Frontiers in pharmacology
|August 1, 2024
概括
这项研究分析了FDA不良事件报告系统数据,以确定eplerenone的不良药物反应 (ADR). 它证实了已知的不良反应,并发现了未在药物上列出的潜在的新反应.
科学领域:
- 药监和药物安全 药监和药物安全
- 心血管药理学心血管药理学
- 监管科学 监管科学
背景情况:
- 埃普莱伦用于高血压和心脏衰竭后心肌梗塞.
- 对eplerenone的药物不良反应 (ADR) 缺乏系统的分析.
- 识别新的不良反应可以改善药物安全标签.
研究的目的:
- 使用FDA不良事件报告系统 (FAERS) 数据库识别和分析与eplerenone相关的ADR.
- 为了检测与eplerenone相关的潜在以前未报告的不良药物反应.
- 为eplerenone药物标签的潜在更新提供数据.
主要方法:
- 利用四个算法 (ROR,PRR,BCPNN,EBGM) 来评估ADRs的信号强度.
- 从FAERS数据库 (2004-2023) 中分析了1874份过的病例报告.
- 针对与eplerenone相关的事件,研究了27个器官系统的ADRs.
主要成果:
- 鉴定了128个与eplerenone相关的ADR,从总共有1070个已确定的AE中.
- 已确认的已知的副作用,如高胆血症和肌氨酸增加.
- 发现eplerenone的标签遗漏了某些器官系统类别,包括血管和肝胆道疾病.
结论:
- 该研究确定了eplerenone的已知和潜在的新型ADR.
- 需要进一步的研究来证实新发现的副作用的相关性.
- 结果提供了关于eplerenone的安全性概况的见解,帮助医疗保健提供者适当使用它.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:11Renal Failure: Dose Adjustments
77
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
77
01:17Factors Affecting Renal Clearance: Renal Impairment
69
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
69
01:25Antihypertensive Drugs: Direct Renin Inhibitors
521
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
521
01:12Analysis of Population Pharmacokinetic Data
244
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
244
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
199
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
199